T1	intervention 0 10	HydrosorbÂ®
T2	control 18 45	control (water based spray)
T3	condition 67 94	radio-induced skin toxicity
T4	eligibility 273 372	patients (pts) treated for early stage breast cancer (BC) with normo fractionated radiotherapy (RT)
T5	outcome-Measure 481 504	local treatment failure
T6	outcome-Measure 643 673	evaluation of skin colorimetry
T7	outcome-Measure 675 679	pain
T8	outcome-Measure 681 696	quality of life
T9	total-participants 698 723	Two-hundred seventy-eight
T10	total-participants 754 757	186
T11	outcome 798 808	"failures"
T12	iv-bin-abs 795 797	60
T13	cv-bin-abs 836 838	62
T15	iv-bin-abs 1116 1127	Forty-eight
T16	outcome 1165 1171	VAS >2
T17	cv-bin-abs 1179 1181	51
T18	iv-bin-percent 1211 1214	34%
T19	cv-bin-percent 1219 1222	38%
T20	outcome 1274 1278	pain
T14	outcome 975 1007	reduction of colorimetric levels
T21	iv-cont-mean 1037 1038	4
T22	cv-cont-mean 1062 1065	4.2
